Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6841561 | 1.00 | FFAR3 (0.33) | FFAR3CYP3A4 | |
| SCHEMBL5035603 | 0.76 | MEN1 (0.33) | — | |
| SCHEMBL6841376 | 0.74 | — | — | |
| SCHEMBL7528758 | 0.72 | ALDH1A1 (0.39) | — | |
| SCHEMBL11884458 | 0.69 | LMNA (0.31) | — | |
| SCHEMBL4998504 | 0.68 | — | — | |
| Acetic Acid SCHEMBL3448204 | 0.64 | FFAR3 (0.33) | FFAR3CYP3A4 | |
| SCHEMBL8356300 | 0.64 | — | — | |
| SCHEMBL3985967 | 0.63 | FFAR3 (0.43) | FFAR3 | |
| SCHEMBL126906 | 0.63 | FFAR3 (0.32) | FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040167351-A1 | Method for preparing (1R,4S)-2-azabicyclo[2.2.1]hept-5-ene-3-one derivatives | BERNEGGER-EGLI CHRISTINE (CH) | 2004-08-26 | — | — | US | disclosed |
| US-6780634-B1 | Method for producing (1R,4S)-2-azabicyclo[2.2.1]-hept-5-en-3-on derivatives | LONZA AG (CH) | 2004-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167351-A1 | Method for preparing (1R,4S)-2-azabicyclo[2.2.1]hept-5-ene-3-one derivatives | APEH, CYP51A1, CYP8B1 | FFAR3 2195/4885CYP3A4 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.